<DOC>
	<DOCNO>NCT00960050</DOCNO>
	<brief_summary>RATIONALE : Gathering information patient childhood hematologic cancer aplastic anemia treat dapsone may help doctor learn risk factor develop methemoglobinemia . PURPOSE : This phase I trial study methemoglobinemia patient childhood hematologic cancer aplastic anemia treat dapsone .</brief_summary>
	<brief_title>Methemoglobinemia Patients With Childhood Hematologic Cancer Aplastic Anemia Treated With Dapsone</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine host-related risk factor develop symptomatic methemoglobinemia patient pediatric hematologic malignancy aplastic anemia receive dapsone prophylaxis pneumocystis carinii . - Determine whether deficiency cytochrome b5 reductase risk factor symptomatic methemoglobinemia subset patient . Secondary - Collect genomic DNA specimen subset patient enzyme test conduct store future analyse variation gene responsible cytochrome b5 reductase . OUTLINE : Patients ' medical record review possible risk factor ( e.g. , age , sex , body mass index ) develop symptomatic methemoglobinemia . A subset patient undergo blood sample collection analysis cytochrome b5 reductase level . DNA sample also collect patient future genetic polymorphism study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Methemoglobinemia</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis hematologic malignancy aplastic anemia within past 15 year Division Pediatric Hematology/Oncology Vanderbilt University Previously treat dapsone prophylaxis pneumocystis carinii May may symptomatic methemoglobinemia PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>methemoglobinemia</keyword>
	<keyword>aplastic anemia</keyword>
	<keyword>childhood acute lymphoblastic leukemia</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>juvenile myelomonocytic leukemia</keyword>
	<keyword>childhood Hodgkin lymphoma</keyword>
	<keyword>childhood large cell lymphoma</keyword>
	<keyword>childhood lymphoblastic lymphoma</keyword>
	<keyword>childhood small noncleaved cell lymphoma</keyword>
	<keyword>childhood anaplastic large cell lymphoma</keyword>
	<keyword>childhood diffuse large cell lymphoma</keyword>
	<keyword>childhood grade III lymphomatoid granulomatosis</keyword>
	<keyword>childhood immunoblastic large cell lymphoma</keyword>
	<keyword>childhood nasal type extranodal NK/T-cell lymphoma</keyword>
	<keyword>childhood myelodysplastic syndrome</keyword>
</DOC>